Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Rendell

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|February 22, 2019
Premix insulins in type 1 diabetes: the coming of degludec/aspartMarc Rendell
Expert Opinion on Pharmacotherapy|March 13, 2025
Pharmacotherapy of type 1 diabetes - part 2 TodayMarc Rendell
Expert Opinion on Pharmacotherapy|March 8, 2025
Pharmacotherapy of type 1 diabetes - part 3: tomorrowMarc Rendell
NEJM Evidence|June 23, 2026
Berberine-Ursodeoxycholate - Bringing Traditional Chinese Medicine to Our WorldBinh Ngo, Marc Rendell
Medgenmed : Medscape General Medicine|January 14, 2005
Advances in diabetes for the millennium: an e-symposiumMarc Rendell, George D Lundberg
Postgraduate Medicine|June 18, 2011
Review of the safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled studyMarc Rendell, Steven G Chrysant
The American Journal of Medicine|July 3, 2007
Bleeding toes in diabetic neuropathyPankaj Shah, Binh Ngo, Marc Rendell
Archives of Dermatology|October 20, 2004
Skin blood flow in diabetic dermopathyGreg Wigington, Binh Ngo, Marc Rendell
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 26, 2011
Alogliptin: a new addition to the class of DPP-4 inhibitorsRadha Andukuri, Andjela Drincic, Marc Rendell
Expert Opinion on Pharmacotherapy|February 3, 2012
Alogliptin benzoate for the treatment of type 2 diabetesMarc Rendell, Andjela Drincic, Radha Andukuri
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Expert Opinion on Drug Metabolism & Toxicology|February 22, 2019
Premix insulins in type 1 diabetes: the coming of degludec/aspartMarc Rendell
Expert Opinion on Pharmacotherapy|March 13, 2025
Pharmacotherapy of type 1 diabetes - part 2 TodayMarc Rendell
Expert Opinion on Pharmacotherapy|March 8, 2025
Pharmacotherapy of type 1 diabetes - part 3: tomorrowMarc Rendell
NEJM Evidence|June 23, 2026
Berberine-Ursodeoxycholate - Bringing Traditional Chinese Medicine to Our WorldBinh Ngo, Marc Rendell
Medgenmed : Medscape General Medicine|January 14, 2005
Advances in diabetes for the millennium: an e-symposiumMarc Rendell, George D Lundberg
Postgraduate Medicine|June 18, 2011
Review of the safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled studyMarc Rendell, Steven G Chrysant
The American Journal of Medicine|July 3, 2007
Bleeding toes in diabetic neuropathyPankaj Shah, Binh Ngo, Marc Rendell
Archives of Dermatology|October 20, 2004
Skin blood flow in diabetic dermopathyGreg Wigington, Binh Ngo, Marc Rendell
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 26, 2011
Alogliptin: a new addition to the class of DPP-4 inhibitorsRadha Andukuri, Andjela Drincic, Marc Rendell
Expert Opinion on Pharmacotherapy|February 3, 2012
Alogliptin benzoate for the treatment of type 2 diabetesMarc Rendell, Andjela Drincic, Radha Andukuri
Pageof 5